NEOG Logo

Neogen Corporation (NEOG) 

NASDAQ
Market Cap
$3.25B
Sector
Healthcare
Industry
Medical—Diagnostics & Research
Rank in Sector
113 of 775
Rank in Industry
6 of 42

Largest Insider Buys in Sector

NEOG Stock Price History Chart

NEOG Stock Performance

About Neogen Corporation

Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general …

Insider Activity of Neogen Corporation

Over the last 12 months, insiders at Neogen Corporation have bought $912,759 and sold $0 worth of Neogen Corporation stock.

On average, over the past 5 years, insiders at Neogen Corporation have bought $483,361 and sold $11.97M worth of stock each year.

Highest buying activity among insiders over the last 12 months: ADENT JOHN EDWARD (CEO) — $484,290. Naemura David H. (CFO) — $312,643. Jones Douglas Edward (Chief Operating Officer) — $123,590.

The last purchase of 14,500 shares for transaction amount of $200,100 was made by ADENT JOHN EDWARD (CEO) on 2024‑10‑11.

List of Insider Buy and Sell Transactions, Neogen Corporation

2024-10-11PurchaseCEO
14,500
0.0055%
$13.80$200,100+1.11%
2024-08-06Purchasedirector
3,000
0.0014%
$16.86$50,571-6.21%
2024-04-17PurchaseChief Operating Officer
10,000
0.0047%
$12.36$123,590+28.40%
2024-04-11Purchasedirector
7,500
0.0035%
$13.06$97,986+18.85%
2024-04-10PurchaseCEO
23,000
0.0105%
$12.36$284,190+23.48%
2024-04-10PurchaseCFO
12,500
0.0058%
$12.51$156,321+23.48%
2023-11-03Purchasedirector
2,000
0.0009%
$16.05$32,110+2.09%
2023-10-25PurchaseChief Operating Officer
10,000
0.0047%
$15.17$151,727+7.94%
2023-10-13SaleVice President
351
0.0002%
$15.10$5,300+4.27%
2023-10-12Purchasedirector
3,000
0.0014%
$15.19$45,567+7.75%
2023-10-11SaleVice President
1,917
0.0009%
$15.69$30,087+7.68%
2023-10-11Saledirector
2,591
0.0012%
$15.61$40,456+7.68%
2023-10-11PurchaseCFO
10,000
0.0046%
$15.03$150,333+7.68%
2023-08-18Saledirector
1,500
0.0007%
$22.59$33,891-26.80%
2023-01-13PurchaseChief Operating Officer
2,500
0.0012%
$17.91$44,775+4.14%
2022-10-11PurchaseVP & CFO
5,000
0.0023%
$11.63$58,150+56.59%
2022-10-03Purchasedirector
2,000
0.0009%
$13.88$27,770
2022-08-16Purchase
1,100
0.001%
$21.83$24,013-19.56%
2022-08-02Purchase
1,500
0.0014%
$22.50$33,750-20.22%
2022-07-29PurchasePresident & CEO
17,500
0.0162%
$23.07$403,725-23.82%

Insider Historical Profitability

11.44%
ADENT JOHN EDWARDCEO
216477
0.0999%
$14.9863+1.51%
Jones Douglas EdwardChief Operating Officer
46131
0.0213%
$14.9840<0.0001%
Naemura David H.CFO
30040
0.0139%
$14.9820
Tobin James Pdirector
23392
0.0108%
$14.9870<0.0001%
BOREL JAMES Cdirector
21392
0.0099%
$14.9820<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
BlackRock$387.38M11.3324.55M-1.22%-$4.79M0.01
The Vanguard Group$311.12M9.119.72M+0.87%+$2.67M0.01
Select Equity Group, L.P.$199.07M5.8212.62M+50.8%+$67.06M0.72
Baillie Gifford Co$186.04M5.4411.79M+42.27%+$55.27M0.15
State Street$119.3M3.497.56M+1.35%+$1.58M0.01
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.